Tristan Gallenne - Concepedia

Author

Tristan Gallenne

Merus (Netherlands)

Also Known As

Gallenne, T., T. Gallenne, Tristan Gallenne

Publications

798

Citations

H-Index

Concepts

All Affiliations

Merus (Netherlands)The Netherlands Cancer Institute Delft University of Technology Harvard University Inserm

About

Tristan Gallenne is an author at Merus (Netherlands) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	415
2	Cell Biology	4	4	415
3	Immunology	2	2	123
4	Engineering	1	1	49
5	Molecular Biology	1	1	243

Tristan Gallenne

Publications

764

Citations

H-Index

Page 1

	Year	Citations
The First α Helix of Bax Plays a Necessary Role in Its Ligand-Induced Activation by the BH3-Only Proteins Bid and PUMA Pierre‐François Cartron, Tristan Gallenne, Gwenola Bougras, Molecular Cell Protein FunctionSignal TransductionMolecular PhysiologyBh3-only Proteins BidMolecular Biology	2004	243
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis Christophe Desmet, Tristan Gallenne, Alexandre Prieur, Proceedings of the National Academy of Sciences	2013	183
The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death Florence Manero, Fabien Gautier, Tristan Gallenne, Cancer Research	2006	130
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade Cecile Geuijen, Camilla De Nardis, David Maussang, Cancer Cell Signal TransductionSignaling PathwayReceptor Tyrosine KinaseBispecific Igg1Immunology	2018	105
Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer Tristan Gallenne, Kenneth N. Ross, Nils L. Visser, Oncotarget Breast Cancer GrowthBreast OncologyEngineeringGeneticsHuman Breast Cancer	2017	49
Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x <sub>L</sub> Fabien Gautier, Yannis Guillemin, Pierre‐François Cartron, Molecular and Cellular Biology	2010	36
Preclinical activity of MCLA-128, an ADCC enhanced bispecific IgG1 antibody targeting the HER2:HER3 heterodimer. Cecile Geuijen, Eric Rovers, Roy Nijhuis, Journal of Clinical Oncology ImmunologyImmunotherapyCancer BiologyTumor BiologyTumor Immunity	2014	18

Page 1